Pharmacogenetics of type 2 diabetes mellitus, the route toward tailored medicine
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacogenetics of type 2 diabetes mellitus, the route toward tailored medicine
Authors
Keywords
-
Journal
DIABETES-METABOLISM RESEARCH AND REVIEWS
Volume -, Issue -, Pages e3109
Publisher
Wiley
Online
2018-12-05
DOI
10.1002/dmrr.3109
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacogenetics of oral antidiabetes drugs: evidence for diverse signals at the IRS1 locus
- (2017) S Prudente et al. PHARMACOGENOMICS JOURNAL
- CYP2C8 and SLCO1B1 Variants and Therapeutic Response to Thiazolidinediones in Patients With Type 2 Diabetes
- (2016) Adem Y. Dawed et al. DIABETES CARE
- A missense variant inGLP1Rgene is associated with the glycaemic response to treatment with gliptins
- (2016) M. Javorský et al. DIABETES OBESITY & METABOLISM
- Single nucleotide polymorphisms in the intergenic region between metformin transporter OCT2 and OCT3 coding genes are associated with short-term response to metformin monotherapy in type 2 diabetes mellitus patients
- (2016) Linda Zaharenko et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- The MATE1 rs2289669 polymorphism affects the renal clearance of metformin following ranitidine treatment
- (2016) Sung Kweon Cho et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin
- (2016) Kaixin Zhou et al. NATURE GENETICS
- Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
- (2016) Walter N. Kernan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Joint effects of diabetic-related genomic loci on the therapeutic efficacy of oral anti-diabetic drugs in Chinese type 2 diabetes patients
- (2016) Miao Chen et al. Scientific Reports
- Genomic Characterization of Metformin Hepatic Response
- (2016) Marcelo R. Luizon et al. PLoS Genetics
- Racial/ethnic disparities in prevalence and care of patients with type 2 diabetes mellitus
- (2015) Keith C. Ferdinand et al. CURRENT MEDICAL RESEARCH AND OPINION
- The variant organic cation transporter 2 (OCT2)–T201M contribute to changes in insulin resistance in patients with type 2 diabetes treated with metformin
- (2015) Zahra Kashi et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- SLC47A1 gene rs2289669 G>A variants enhance the glucose-lowering effect of metformin via delaying its excretion in Chinese type 2 diabetes patients
- (2015) Rui He et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Frailty and geography: should these two factors be added to the ABCDE contemporary guide to diabetes therapy?
- (2015) Ernesto Maddaloni et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Organic cation transporter 1 variants and gastrointestinal side effects of metformin in patients with Type 2 diabetes
- (2015) T. Dujic et al. DIABETIC MEDICINE
- Innate biology versus lifestyle behaviour in the aetiology of obesity and type 2 diabetes: the GLACIER Study
- (2015) Alaitz Poveda et al. DIABETOLOGIA
- Genetic variability in GLP-1 receptor is associated with inter-individual differences in weight lowering potential of liraglutide in obese women with PCOS: a pilot study
- (2015) Mojca Jensterle et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Evaluation of weight loss and metabolic changes in diabetic patients treated with liraglutide, effect of RS 6923761 gene variant of glucagon-like peptide 1 receptor
- (2015) Daniel Antonio de Luis et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- The Effect of Intensive Glucose Lowering Therapy Among Major Racial/Ethnic Groups in the Veterans Affairs Diabetes Trial
- (2015) Aramesh Saremi et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Polymorphism of Organic Cation Transporter 2 Improves Glucose-Lowering Effect of Metformin via Influencing Its Pharmacokinetics in Chinese Type 2 Diabetic Patients
- (2015) Wolin Hou et al. Molecular Diagnosis & Therapy
- Role of SLC22A1 polymorphic variants in drug disposition, therapeutic responses and drug–drug interactions
- (2015) C Arimany-Nardi et al. PHARMACOGENOMICS JOURNAL
- Multidrug and toxin extrusion 1 and human organic cation transporter 1 polymorphisms in patients with castration-resistant prostate cancer receiving metformin (SAKK 08/09)
- (2015) M Joerger et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility
- (2015) Jennifer Wessel et al. Nature Communications
- Identification and Functional Characterization of G6PC2 Coding Variants Influencing Glycemic Traits Define an Effector Transcript at the G6PC2-ABCB11 Locus
- (2015) Anubha Mahajan et al. PLoS Genetics
- Role of the rs6923761 Gene Variant in Glucagon-Like Peptide 1 Receptor Gene on Cardiovascular Risk Factors and Weight Loss after Biliopancreatic Diversion Surgery
- (2014) Daniel Antonio de Luis et al. ANNALS OF NUTRITION AND METABOLISM
- Sulfonylureas: A New Look at Old Therapy
- (2014) Peter M. Thulé et al. Current Diabetes Reports
- IRS1 G972R Missense Polymorphism Is Associated With Failure to Oral Antidiabetes Drugs in White Patients With Type 2 Diabetes From Italy
- (2014) S. Prudente et al. DIABETES
- Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium
- (2014) Nicholette D. Palmer et al. DIABETES
- Influence of TCF7L2 gene variants on the therapeutic response to the dipeptidylpeptidase-4 inhibitor linagliptin
- (2014) Heike Zimdahl et al. DIABETOLOGIA
- CYP2C9, KCNJ11 and ABCC8 polymorphisms and the response to sulphonylurea treatment in type 2 diabetes patients
- (2014) Jasna Klen et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- CYP2C9*2 Allele Increases Risk for Hypoglycemia in POR*1/*1 Type 2 Diabetic Patients Treated with Sulfonylureas
- (2014) G. Ragia et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Relation of the rs6923761 Gene Variant in Glucagon-Like Peptide 1 Receptor with Weight, Cardiovascular Risk Factor, and Serum Adipokine Levels in Obese Female Subjects
- (2014) Daniel Antonio de Luis et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- A Naturally Occurring GIP Receptor Variant Undergoes Enhanced Agonist-Induced Desensitization, Which Impairs GIP Control of Adipose Insulin Sensitivity
- (2014) S. Mohammad et al. MOLECULAR AND CELLULAR BIOLOGY
- A Combined Analysis of 48 Type 2 Diabetes Genetic Risk Variants Shows No Discriminative Value to Predict Time to First Prescription of a Glucose Lowering Drug in Danish Patients with Screen Detected Type 2 Diabetes
- (2014) Malene Hornbak et al. PLoS One
- Adiponectin Gene Polymorphism rs2241766 T/G Is Associated with Response to Pioglitazone Treatment in Type 2 Diabetic Patients from Southern China
- (2014) Hong Yang et al. PLoS One
- The Role of Genetic Factors and Kidney and Liver Function in Glycemic Control in Type 2 Diabetes Patients on Long-Term Metformin and Sulphonylurea Cotreatment
- (2014) Jasna Klen et al. Biomed Research International
- Role of rs6923761 gene variant in glucagon-like peptide 1 receptor in basal GLP-1 levels, cardiovascular risk factor and serum adipokine levels in naïve type 2 diabetic patients
- (2014) D. A. de Luis et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Cardiovascular risk factors and adipocytokines levels after two hypocaloric diets with different fat distribution in obese subjects and rs6923761 gene variant of glucagon-like peptide 1 receptor
- (2014) Daniel Antonio de Luis et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Heritability of variation in glycaemic response to metformin: a genome-wide complex trait analysis
- (2014) Kaixin Zhou et al. Lancet Diabetes & Endocrinology
- Influences of Organic Cation Transporter Polymorphisms on the Population Pharmacokinetics of Metformin in Healthy Subjects
- (2013) Hwa Yoon et al. AAPS Journal
- Effect of Cytochrome P450 2C8*3 on the Population Pharmacokinetics of Pioglitazone in Healthy Caucasian Volunteers
- (2013) Rajendra Kadam et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Population Pharmacokinetics of Metformin in Healthy Subjects and Patients with Type 2 Diabetes Mellitus: Simulation of Doses According to Renal Function
- (2013) Janna K. Duong et al. CLINICAL PHARMACOKINETICS
- Link Between GIP and Osteopontin in Adipose Tissue and Insulin Resistance
- (2013) E. Ahlqvist et al. DIABETES
- Effect of ABCB1 polymorphisms and atorvastatin on sitagliptin pharmacokinetics in healthy volunteers
- (2013) Christina L. Aquilante et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- The Cardiovascular Safety of Diabetes Drugs — Insights from the Rosiglitazone Experience
- (2013) William R. Hiatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- A gene–gene interaction between polymorphisms in the OCT2 and MATE1 genes influences the renal clearance of metformin
- (2013) Mette M.H. Christensen et al. Pharmacogenetics and Genomics
- Functional characterization of MATE2-K genetic variants and their effects on metformin pharmacokinetics
- (2013) Jae-Yong Chung et al. Pharmacogenetics and Genomics
- The role of genetic variants in CYP2C8, LPIN1, PPARGC1A and PPARγ on the trough steady-state plasma concentrations of rosiglitazone and on glycosylated haemoglobin A1c in type 2 diabetes
- (2013) Tore B. Stage et al. Pharmacogenetics and Genomics
- Influence ofCYP2C8*2on the Pharmacokinetics of Pioglitazone in Healthy African-American Volunteers
- (2013) Christina L. Aquilante et al. PHARMACOTHERAPY
- Effects ofNOS1APrs12742393 Polymorphism on Repaglinide Response in Chinese Patients with Type 2 Diabetes Mellitus
- (2013) Tao Wang et al. PHARMACOTHERAPY
- Kir6.2E23K polymorphism is related to secondary failure of sulfonylureas in non-obese patients with type 2 diabetes
- (2013) Yoshinori Shimajiri et al. Journal of Diabetes Investigation
- Current clinical evidence on pioglitazone pharmacogenomics
- (2013) Marina Kawaguchi-Suzuki et al. Frontiers in Pharmacology
- PPAR-γ2 and PTPRD gene polymorphisms influence type 2 diabetes patients' response to pioglitazone in China
- (2012) Qi Pei et al. ACTA PHARMACOLOGICA SINICA
- Genetic variants of organic cation transporter 1 (OCT1) and OCT2 significantly reduce lamivudine uptake
- (2012) Min-Koo Choi et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Impact of theCYP2C8*3polymorphism on the drug-drug interaction between gemfibrozil and pioglitazone
- (2012) Christina L. Aquilante et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Loss of multidrug and toxin extrusion 1 (MATE1) is associated with metformin-induced lactic acidosis
- (2012) K Toyama et al. BRITISH JOURNAL OF PHARMACOLOGY
- KCNQ1 gene polymorphisms are associated with the therapeutic efficacy of repaglinide in Chinese Type 2 diabetic patients
- (2012) Xing-Ping Dai et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Diabetes-Associated Common Genetic Variation and Its Association With GLP-1 Concentrations and Response to Exogenous GLP-1
- (2012) Galina Smushkin et al. DIABETES
- The C Allele of ATM rs11212617 Does Not Associate With Metformin Response in the Diabetes Prevention Program
- (2012) J. C. Florez et al. DIABETES CARE
- Pharmacogenomic association between a variant inSLC47A1gene and therapeutic response to metformin in type 2 diabetes
- (2012) I. Tkáč et al. DIABETES OBESITY & METABOLISM
- Association of KCNJ11 E23K gene polymorphism with hypoglycemia in sulfonylurea-treated Type 2 diabetic patients
- (2012) Georgia Ragia et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of five cohorts
- (2012) N. van Leeuwen et al. DIABETOLOGIA
- Effect of CYP2C9 and SLCO1B1 polymorphisms on the pharmacokinetics and pharmacodynamics of nateglinide in healthy Chinese male volunteers
- (2012) Yu Cheng et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- ABCC8 Polymorphisms Are Associated with Triglyceride Concentration in Type 2 Diabetics on Sulfonylurea Therapy
- (2012) Nora Nikolac et al. Genetic Testing and Molecular Biomarkers
- Individualized Therapy for Type 2 Diabetes
- (2012) Gaia Chiara Mannino et al. Molecular Diagnosis & Therapy
- Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes
- (2012) NATURE GENETICS
- Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways
- (2012) Robert A Scott et al. NATURE GENETICS
- A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance
- (2012) Alisa K Manning et al. NATURE GENETICS
- Association of genetic variation in the organic cation transporters OCT1, OCT2 and multidrug and toxin extrusion 1 transporter protein genes with the gastrointestinal side effects and lower BMI in metformin-treated type 2 diabetes patients
- (2012) Linda Tarasova et al. Pharmacogenetics and Genomics
- Multi-ethnic distribution of clinically relevant CYP2C genotypes and haplotypes
- (2012) S Martis et al. PHARMACOGENOMICS JOURNAL
- The Influence of MDR1 G2677T/A Genetic Polymorphisms on the Pharmacokinetics of Repaglinide in Healthy Chinese Volunteers
- (2012) Qian Xiang et al. PHARMACOLOGY
- TCF7L2 and therapeutic response to sulfonylureas in patients with type 2 diabetes
- (2011) Andreas Holstein et al. BMC Medical Genetics
- Effect of genetic polymorphisms on the pharmacokinetics and efficacy of glimepiride in a Korean population
- (2011) Hyun-Jung Cho et al. CLINICA CHIMICA ACTA
- Clinical Pharmacokinetics of Metformin
- (2011) Garry G. Graham et al. CLINICAL PHARMACOKINETICS
- Effects of KCNQ1 Polymorphisms on the Therapeutic Efficacy of Oral Antidiabetic Drugs in Chinese Patients With Type 2 Diabetes
- (2011) W Yu et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A Common 5′-UTR Variant in MATE2-K Is Associated With Poor Response to Metformin
- (2011) J H Choi et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pleiotropic Effects of GIP on Islet Function Involve Osteopontin
- (2011) V. Lyssenko et al. DIABETES
- Evaluation of CYP2C8 Inhibition In Vitro: Utility of Montelukast as a Selective CYP2C8 Probe Substrate
- (2011) B. M. VandenBrink et al. DRUG METABOLISM AND DISPOSITION
- Discovery of a Novel Allelic Variant of CYP2C8, CYP2C8*11, in Asian Populations and Its Clinical Effect on the Rosiglitazone Disposition In Vivo
- (2011) C.-W. Yeo et al. DRUG METABOLISM AND DISPOSITION
- Mild hypoglycaemic attacks induced by sulphonylureas related to CYP2C9, CYP2C19 and CYP2C8 polymorphisms in routine clinical setting
- (2011) Osman Gökalp et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Impact of clinical factors and CYP2C9 variants for the risk of severe sulfonylurea-induced hypoglycemia
- (2011) Andreas Holstein et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Effects of SLCO1B1 polymorphisms on the pharmacokinetics and pharmacodynamics of repaglinide in healthy Chinese volunteers
- (2011) Jiake He et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Influence of CYP2C9 gene polymorphisms on response to glibenclamide in type 2 diabetes mellitus patients
- (2011) A. Surendiran et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- KCNJ11 gene E23K variant and therapeutic response to sulfonylureas
- (2011) Martin Javorsky et al. European Journal of Internal Medicine
- Polymorphism of peroxisome proliferator-activated receptor γ (PPARγ) Pro12Ala in the Iranian population: Relation with insulin resistance and response to treatment with pioglitazone in type 2 diabetes
- (2011) Fatemeh Namvaran et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Polymorphism of adiponectin (45T/G) and adiponectin receptor-2 (795G/A) in an Iranian population: relation with insulin resistance and response to treatment with pioglitazone in patients with type 2 diabetes mellitus
- (2011) Fatemeh Namvaran et al. MOLECULAR BIOLOGY REPORTS
- Polymorphism and Ligand Dependent Changes in Human Glucagon-Like Peptide-1 Receptor (GLP-1R) Function: Allosteric Rescue of Loss of Function Mutation
- (2011) C. Koole et al. MOLECULAR PHARMACOLOGY
- The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c
- (2011) Mette M.H. Christensen et al. Pharmacogenetics and Genomics
- Pharmacogenomic analysis of ATP-sensitive potassium channels coexpressing the common type 2 diabetes risk variants E23K and S1369A
- (2011) Veronica Y. Lang et al. Pharmacogenetics and Genomics
- The Ser1369Ala variant of ABCC8 and the risk for severe sulfonylurea-induced hypoglycemia in German patients with Type 2 diabetes
- (2011) Judith Dina Holstein et al. PHARMACOGENOMICS
- Effect of genetic polymorphisms on the development of secondary failure to sulfonylurea in Egyptian patients with type 2 diabetes
- (2011) Alaa E. El-sisi et al. Therapeutic Advances in Endocrinology and Metabolism
- A variation in NOS1AP gene is associated with repaglinide efficacy on insulin resistance in type 2 diabetes of Chinese
- (2010) Wen Qin et al. ACTA PHARMACOLOGICA SINICA
- The Association Between the Peroxisome Proliferator-Activated Receptor-γ2 (PPARG2) Pro12Ala Gene Variant and Type 2 Diabetes Mellitus: A HuGE Review and Meta-Analysis
- (2010) Hebe N. Gouda et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Effect of Rosiglitazone on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease
- (2010) Hertzel C. Gerstein et al. CIRCULATION
- KCNJ11 Lys23Glu and TCF7L2 rs290487(C/T) Polymorphisms Affect Therapeutic Efficacy of Repaglinide in Chinese Patients With Type 2 Diabetes
- (2010) M Yu et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Common Variants in 40 Genes Assessed for Diabetes Incidence and Response to Metformin and Lifestyle Intervention in the Diabetes Prevention Program
- (2010) K. A. Jablonski et al. DIABETES
- Common Genetic Variation in GLP1R and Insulin Secretion in Response to Exogenous GLP-1 in Nondiabetic Subjects: A pilot study
- (2010) A. Sathananthan et al. DIABETES CARE
- Genetic variants of the insulin receptor substrate-1 are influencing the therapeutic efficacy of oral antidiabetics
- (2010) A. Seeringer et al. DIABETES OBESITY & METABOLISM
- The A1C and ABCD of glycaemia management in type 2 diabetes: a physician's personalized approach
- (2010) Paolo Pozzilli et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Effects of the Peroxisome Proliferator Activated Receptor-γ Coactivator-1α(PGC-1α) Thr394ThrandGly482SerPolymorphisms on Rosiglitazone Response in Chinese Patients With Type 2 Diabetes Mellitus
- (2010) Ke-Han Zhang et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Genetic Polymorphisms in Organic Cation Transporter 1 (OCT1) in Chinese and Japanese Populations Exhibit Altered Function
- (2010) L. Chen et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Common polymorphisms of the peroxisome proliferator-activated receptor–γ (Pro12Ala) and peroxisome proliferator-activated receptor–γ coactivator–1 (Gly482Ser) and the response to pioglitazone in Chinese patients with type 2 diabetes mellitus
- (2010) Ming-Chia Hsieh et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes
- (2010) Kaixin Zhou et al. NATURE GENETICS
- Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index
- (2010) Elizabeth K Speliotes et al. NATURE GENETICS
- Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge
- (2010) Richa Saxena et al. NATURE GENETICS
- New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk
- (2010) Josée Dupuis et al. NATURE GENETICS
- Weighing Risks and Benefits of Liraglutide — The FDA's Review of a New Antidiabetic Therapy
- (2010) Mary Parks et al. NEW ENGLAND JOURNAL OF MEDICINE
- Common variation in the NOS1AP gene is associated with reduced glucose-lowering effect and with increased mortality in users of sulfonylurea
- (2010) Matthijs L. Becker et al. Pharmacogenetics and Genomics
- OCT2 polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine
- (2010) Zhi-Jun Wang et al. Pharmacogenetics and Genomics
- Heterozygous variants of multidrug and toxin extrusions (MATE1 and MATE2-K) have little influence on the disposition of metformin in diabetic patients
- (2010) Kana Toyama et al. Pharmacogenetics and Genomics
- ABCC8polymorphism (Ser1369Ala): influence on severe hypoglycemia due to sulfonylureas
- (2010) Ryosuke Sato et al. PHARMACOGENOMICS
- Effect ofCYP2C9polymorphisms on prescribed dose and time-to-stable dose of sulfonylureas in primary care patients with Type 2 diabetes mellitus
- (2010) Jesse J Swen et al. PHARMACOGENOMICS
- Exenatide is Non-inferior to Insulin in Reducing HbA1c: An Integrated Analysis of 1423 Patients with Type 2 Diabetes
- (2010) Thomas Blevins et al. POSTGRADUATE MEDICINE
- A Genome-Wide Association Study Identifies Susceptibility Variants for Type 2 Diabetes in Han Chinese
- (2010) Fuu-Jen Tsai et al. PLoS Genetics
- Metabolic Control in Type 2 Diabetes Is Associated with Sulfonylurea Receptor-1 (SUR-1) but Not with KCNJ11 Polymorphisms
- (2009) Nora Nikolac et al. ARCHIVES OF MEDICAL RESEARCH
- Association between TCF7L2gene polymorphisms and susceptibility to Type 2 Diabetes Mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis
- (2009) Yu Tong et al. BMC Medical Genetics
- The Effects of Genetic Polymorphisms in the Organic Cation Transporters OCT1, OCT2, and OCT3 on the Renal Clearance of Metformin
- (2009) M V Tzvetkov et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Loss-of-Function CYP2C9 Variants Improve Therapeutic Response to Sulfonylureas in Type 2 Diabetes: A Go-DARTS Study
- (2009) K Zhou et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Efficacy and safety of biphasic insulin aspart 70/30 versus exenatide in subjects with type 2 diabetes failing to achieve glycemic control with metformin and a sulfonylurea
- (2009) Richard Bergenstal et al. CURRENT MEDICAL RESEARCH AND OPINION
- Coexpression of the Type 2 Diabetes Susceptibility Gene Variants KCNJ11 E23K and ABCC8 S1369A Alter the ATP and Sulfonylurea Sensitivities of the ATP-Sensitive K+ Channel
- (2009) K. S.C. Hamming et al. DIABETES
- A Variant in the KCNQ1 Gene Predicts Future Type 2 Diabetes and Mediates Impaired Insulin Secretion
- (2009) A. Jonsson et al. DIABETES
- Reduced-Function SLC22A1 Polymorphisms Encoding Organic Cation Transporter 1 and Glycemic Response to Metformin: A GoDARTS Study
- (2009) K. Zhou et al. DIABETES
- Association of Type 2 Diabetes Candidate Polymorphisms in KCNQ1 With Incretin and Insulin Secretion
- (2009) K. Mussig et al. DIABETES
- Genetic Variation in the Multidrug and Toxin Extrusion 1 Transporter Protein Influences the Glucose-Lowering Effect of Metformin in Patients With Diabetes: A Preliminary Study
- (2009) M. L. Becker et al. DIABETES
- Association of genetic variants of NOS1AP with type 2 diabetes in a Chinese population
- (2009) C. Hu et al. DIABETOLOGIA
- IRS1 G972R polymorphism and type 2 diabetes: a paradigm for the difficult ascertainment of the contribution to disease susceptibility of ‘low-frequency–low-risk’ variants
- (2009) E. Morini et al. DIABETOLOGIA
- Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial
- (2009) D. Russell-Jones et al. DIABETOLOGIA
- The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men
- (2009) K. Pilgaard et al. DIABETOLOGIA
- The E23K Variant ofKCNJ11and the Risk for Severe Sulfonylurea-induced Hypoglycemia in Patients with Type 2 Diabetes
- (2009) A. Holstein et al. HORMONE AND METABOLIC RESEARCH
- Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function
- (2009) Luan Shu et al. HUMAN MOLECULAR GENETICS
- Identification of multidrug and toxin extrusion (MATE1 and MATE2-K) variants with complete loss of transport activity
- (2009) Moto Kajiwara et al. JOURNAL OF HUMAN GENETICS
- Pharmacological Characterization of Human Incretin Receptor Missense Variants
- (2009) J.-P. Fortin et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin
- (2009) Ying Chen et al. Pharmacogenetics and Genomics
- Interaction between polymorphisms in the OCT1 and MATE1 transporter and metformin response
- (2009) Matthijs L. Becker et al. Pharmacogenetics and Genomics
- Cytochrome P450 2C8 pharmacogenetics: a review of clinical studies
- (2009) Elizabeth B Daily et al. PHARMACOGENOMICS
- Presence ofCYP2C9*3allele increases risk for hypoglycemia in Type 2 diabetic patients treated with sulfonylureas
- (2009) Georgia Ragia et al. PHARMACOGENOMICS
- Genetic variants in multidrug and toxic compound extrusion-1, hMATE1, alter transport function
- (2009) Ying Chen et al. PHARMACOGENOMICS JOURNAL
- Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus
- (2009) M L Becker et al. PHARMACOGENOMICS JOURNAL
- Association ofKCNJ11andABCC8genetic polymorphisms with response to repaglinide in Chinese diabetic patients1
- (2008) Ya-yi HE et al. ACTA PHARMACOLOGICA SINICA
- The association of adiponectin allele 45T/G and −11377C/G polymorphisms with Type 2 diabetes and rosiglitazone response in Chinese patients
- (2008) Hong Sun et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- The effect ofSLCO1B1polymorphism on repaglinide pharmacokinetics persists over a wide dose range
- (2008) Annikka Kalliokoski et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Genetic Variants of the Organic Cation Transporter 2 Influence the Disposition of Metformin
- (2008) IS Song et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Ser1369Ala Variant in Sulfonylurea Receptor Gene ABCC8 Is Associated With Antidiabetic Efficacy of Gliclazide in Chinese Type 2 Diabetic Patients
- (2008) Y. Feng et al. DIABETES CARE
- The influence of adiponectin gene polymorphism on the pioglitazone response in the Chinese with type 2 diabetes
- (2008) DIABETES OBESITY & METABOLISM
- Different Effects ofSLCO1B1Polymorphism on the Pharmacokinetics and Pharmacodynamics of Repaglinide and Nateglinide
- (2008) Annikka Kalliokoski et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Effect of the Pro12Ala polymorphism of the PPARγ2 gene on response to pioglitazone treatment in menopausal women
- (2008) Mónica Ramírez-Salazar et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations
- (2008) Hiroyuki Unoki et al. NATURE GENETICS
- Effects of the SLCO1B1*1B haplotype on the pharmacokinetics and pharmacodynamics of repaglinide and nateglinide
- (2008) Annikka Kalliokoski et al. Pharmacogenetics and Genomics
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started